Teladoc Health, Inc.
TDOCHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Teladoc Health, Inc. focuses on Health Information Services services and products. Teladoc Health, Inc. provides virtual healthcare services worldwide. The company carries a $1.14B market cap, placing it firmly in the small-cap category. It operates through Teladoc Health Integrated Care and BetterHelp segments.
Market Cap
$1.14B
Beta
2.13
P/E (TTM)
—
P/E (Fwd)
-8.00
EPS (TTM)
$-0.96
EPS (Fwd)
$-0.79
ROE
-13.0%
ROA
-3.2%
Cash
$774.3M
Total Debt
$1.04B
Free CF
$191.0M
52W Change
-17.3%
Annual Financials
Cash vs Debt
Where TDOC stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, TDOC finished 3.21% below its 150-day moving average ($6.55) and 5.37% below its 200-day moving average ($6.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TDOC overbought or oversold?
At the September 1, 2026 close, TDOC's RSI(14) was 38.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $774.3M in cash, though total debt stands at $1.04B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $191.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -13.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $2.41B (2022) to $2.53B (2025).
A beta of 2.12 means TDOC is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Teladoc Health, Inc. and its sector.